humanized glp-1 receptor knock-in mouse genO‑hGLP-1R Model | Autoimmunity & Metabolism GLP-1 Orals and Multi-Agonists: Advancing

While all of these potential benefits are exciting, experts said they need much more study, and even then, whether they might ever be utilized as a treatment for schizophrenia, for example, would depend on a number of factors: how much and how consistently they work, as well as how they compare to treatments that are already available

Originally developed for type 2 diabetes, these drugs have now proven to be some of the most powerful tools for sustainable weight loss

Holst JJ, Rosenkilde MM

Who shouldnt take GLP-1s

The 2.4 mg group lost the most weight, which means that among adults suffering from overweight or obesity and T2DM, SMG 2.4 mg once a week has achieved significant clinically significant weight loss (99)

The participants were split into two groups: those without a pre-existing substance use disorder and those who already had a substance use disorder